Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-14-000447
Filing Date
2014-09-05
Accepted
2014-09-05 16:20:55
Documents
1
Period of Report
2014-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 form_3.html 3  
1 FORM 3 form_3.xml 3 5256
  Complete submission text file 0001161697-14-000447.txt   6801
Mailing Address CATALYST PHARMACEUTICAL PARTNERS, INC. 355 ALHAMBRA CIRCLE, SUITE 1500 CORAL GABLES FL 33134
Business Address
MUTH DAVID D (Reporting) CIK: 0001111736 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 141086197

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations